 |
1-(2-chlorophenyl)-1-(S)-hydroxy-2-(S)-carbamoyloxy-propane |
|---|---|
| Trade Name | |
| Orphan Indication | West syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2017-03-20 00:00:00 |
| Sponsor | Bio-Pharm Solutions, Co., Ltd.;6F, C Bldg., Advanced Institute of Convergence Technology, 145 Gwanggyo-Ro, Yeongtong-Gu;Suwon |
